SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-000182
Filing Date
2023-01-03
Accepted
2023-01-03 21:04:55
Documents
2
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 9316
2 ex24.htm EX-24 11142
  Complete submission text file 0001493152-23-000182.txt   21768
Mailing Address C/O ARBUTUS BIOPHARMA 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
HASTINGS DAVID C (Reporting) CIK: 0001237401 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36581 | Film No.: 23504146

Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Issuer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations